Safety and tolerability of the glutamate antagonist cgs 19755 (selfotel) in patients with acute ischemic stroke: Results of a phase iia randomized trial

Stroke

Volumn 26, Issue 4, 1995, Pages 602-605

  Grotta, James ^a,b,c,d   Clark, Wayne ^a,b,c,d   Coull, Bruce ^a,b,c,d   Pettigrew, L Creed ^a,b,c,d   Mackay, Bruce ^a,b,c,d   Goldstein, Larry B ^a,b,c,d   Meissner, Irene ^a,b,c,d   Murphy, Deborah ^a,b,c,d   Larue, Linda ^a,b,c,d  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; GLUTAMATE RECEPTOR ANTAGONIST; PLACEBO;

ADULT; AGED; AGITATION; AREA UNDER THE CURVE; ARTICLE; BRAIN TOXICITY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HALLUCINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PARANOIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PIPECOLIC ACIDS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0028921447     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.26.4.602     Document Type: Article

References (0)